BEDMINSTER, N.J.--(BUSINESS WIRE)--EKR Therapeutics, Inc., a specialty pharmaceutical company focused on commercializing acute-care hospital products, today announced that it has been named Private Company of the Year by the New Jersey Technology Council (NJTC), a more than 1,200 member non-for-profit organization supporting growth in New Jersey’s various technology sectors including health sciences.
